{"transactions":[{"id":767955,"issuer":{"id":721,"kind":"organization","name":"Invivyd, Inc.","symbol":"IVVD"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-21T20:48:22.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":32876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 19, 2026 and vests in full upon the earlier of (i) May 19, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":32876,"derivative":{"exercise_price":1.04,"expiration_date":"2036-05-18","underlying":"Common Stock","underlying_shares":32876},"source":{"system":"sec-edgar","filing":"0001193125-26-234660","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000119312526234660/ownership.xml","form_type":"4"}},{"id":909907,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Share Option (right to  buy)","published_at":"2026-02-12T02:02:02.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 25% of the shares on February 8, 2027, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2030."}],"balance_after":1000000,"derivative":{"exercise_price":12.75,"expiration_date":"2036-02-05","underlying":"Ordinary Shares","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001193125-26-047322","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000119312526047322/ownership.xml","form_type":"4"}},{"id":909906,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-02-12T02:02:02.000Z","date":"2026-02-09","kind":"sale","planned":false,"acquired":false,"shares":10480,"price":13.45,"value":140956.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 9, 2026, the reporting person sold 10,480 ordinary shares solely to cover taxes associated with the vesting of restricted share units (\"RSUs\") on February 8, 2026. These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations."}],"balance_after":275520,"source":{"system":"sec-edgar","filing":"0001193125-26-047322","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000119312526047322/ownership.xml","form_type":"4"}},{"id":909905,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-02-12T02:02:02.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2027 through February 8, 2030."}],"balance_after":286000,"source":{"system":"sec-edgar","filing":"0001193125-26-047322","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000119312526047322/ownership.xml","form_type":"4"}},{"id":1033038,"issuer":{"id":721,"kind":"organization","name":"Invivyd, Inc.","symbol":"IVVD"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-24T21:07:54.000Z","date":"2025-09-22","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on September 22, 2025 and vests over a three-year period, with one-third of the shares subject to the grant vesting on the first anniversary of the grant date and 1/36th of the total shares subject to the grant vesting in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":1.22,"expiration_date":"2035-09-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193125-25-215634","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000119312525215634/ownership.xml","form_type":"4"}},{"id":1055651,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-08-27T01:40:04.000Z","date":"2025-08-22","kind":"sale","planned":true,"acquired":false,"shares":217351,"price":10.098,"value":2194810.398,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $10.00 to $10.27 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":121000,"source":{"system":"sec-edgar","filing":"0000950170-25-111567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000095017025111567/ownership.xml","form_type":"4"}},{"id":1217348,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Share Option (right to buy)","published_at":"2025-03-08T02:05:03.000Z","date":"2025-03-07","kind":"exercise","planned":true,"acquired":false,"shares":48059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options reported in this Form 4 were set to expire on Monday, March 10, 2025. The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These share options are fully vested and have an expiration date of Monday, March 10, 2025."}],"balance_after":0,"derivative":{"exercise_price":2.48,"expiration_date":"2025-03-10","underlying":"Ordinary Shares","underlying_shares":48059},"source":{"system":"sec-edgar","filing":"0000950170-25-035835","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000095017025035835/ownership.xml","form_type":"4"}},{"id":1217347,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Share Option (right to buy)","published_at":"2025-03-08T02:05:03.000Z","date":"2025-03-07","kind":"exercise","planned":true,"acquired":false,"shares":120966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options reported in this Form 4 were set to expire on Monday, March 10, 2025. The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These share options are fully vested and have an expiration date of Monday, March 10, 2025."}],"balance_after":0,"derivative":{"exercise_price":2.48,"expiration_date":"2025-03-10","underlying":"Ordinary Shares","underlying_shares":120966},"source":{"system":"sec-edgar","filing":"0000950170-25-035835","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000095017025035835/ownership.xml","form_type":"4"}},{"id":1217346,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-03-08T02:05:03.000Z","date":"2025-03-07","kind":"sale","planned":true,"acquired":false,"shares":169025,"price":9.57,"value":1617569.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options reported in this Form 4 were set to expire on Monday, March 10, 2025. The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $9.12 to $10.10 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":338351,"source":{"system":"sec-edgar","filing":"0000950170-25-035835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000095017025035835/ownership.xml","form_type":"4"}},{"id":1217345,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-03-08T02:05:03.000Z","date":"2025-03-07","kind":"exercise","planned":true,"acquired":true,"shares":169025,"price":2.48,"value":419182.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options reported in this Form 4 were set to expire on Monday, March 10, 2025. The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024."}],"balance_after":507376,"source":{"system":"sec-edgar","filing":"0000950170-25-035835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000095017025035835/ownership.xml","form_type":"4"}},{"id":1280316,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Share Option (right to buy)","published_at":"2025-02-07T01:00:07.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% of the shares on February 8, 2026, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2029."}],"balance_after":1000000,"derivative":{"exercise_price":11.74,"expiration_date":"2035-02-04","underlying":"Ordinary Shares","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0000950170-25-015681","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000095017025015681/ownership.xml","form_type":"4"}},{"id":1280315,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-02-07T01:00:07.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":121000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2026 through February 8, 2029."}],"balance_after":338351,"source":{"system":"sec-edgar","filing":"0000950170-25-015681","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000095017025015681/ownership.xml","form_type":"4"}},{"id":1349363,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Share Option (right to buy)","published_at":"2024-11-28T02:00:09.000Z","date":"2024-11-25","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These share options are fully vested."}],"balance_after":47778,"derivative":{"exercise_price":2.48,"expiration_date":"2025-03-10","underlying":"Ordinary Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-131691","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000095017024131691/ownership.xml","form_type":"4"}},{"id":1349362,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-11-28T02:00:09.000Z","date":"2024-11-25","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":15,"value":750000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024."}],"balance_after":217351,"source":{"system":"sec-edgar","filing":"0000950170-24-131691","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000095017024131691/ownership.xml","form_type":"4"}},{"id":1349361,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-11-28T02:00:09.000Z","date":"2024-11-25","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":2.48,"value":124000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024."}],"balance_after":267351,"source":{"system":"sec-edgar","filing":"0000950170-24-131691","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000095017024131691/ownership.xml","form_type":"4"}},{"id":1363680,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-11-16T02:00:21.000Z","date":"2024-11-15","kind":"sale","planned":true,"acquired":false,"shares":51234,"price":14.32,"value":733670.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $14.11 to $15.18 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":217351,"source":{"system":"sec-edgar","filing":"0000950170-24-127740","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000095017024127740/ownership.xml","form_type":"4"}},{"id":1384070,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-10-19T00:00:03.000Z","date":"2024-10-16","kind":"sale","planned":true,"acquired":false,"shares":90474,"price":15,"value":1357110.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2024."}],"balance_after":268585,"source":{"system":"sec-edgar","filing":"0000950170-24-115725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000095017024115725/ownership.xml","form_type":"4"}},{"id":1424231,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-08-23T22:00:03.000Z","date":"2024-08-21","kind":"sale","planned":true,"acquired":false,"shares":48366,"price":5.78,"value":279555.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $5.68 to $5.94 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":359059,"source":{"system":"sec-edgar","filing":"0000950170-24-100274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000095017024100274/ownership.xml","form_type":"4"}},{"id":1655280,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Share Option (right to buy)","published_at":"2024-02-08T00:10:13.000Z","date":"2024-02-05","kind":"grant","planned":false,"acquired":true,"shares":1008600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the shares on February 5, 2025, and vests as to an additional 6.25% of the shares quarterly thereafter until February 5, 2028."}],"balance_after":1008600,"derivative":{"exercise_price":3.87,"expiration_date":"2034-02-05","underlying":"Ordinary Shares","underlying_shares":1008600},"source":{"system":"sec-edgar","filing":"0000950170-24-012395","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000095017024012395/ownership.xml","form_type":"4"}},{"id":1854310,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-06-15T20:39:34.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":39875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and become exercisable on the earlier of (i) June 14, 2024 or (ii) the day immediately prior to the date of the next annual meeting of stockholders following the date of grant, in each case subject to the recipient's continued service on the Board at such time."}],"balance_after":39875,"derivative":{"exercise_price":0.539,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":39875},"source":{"system":"sec-edgar","filing":"0001209191-23-037370","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000120919123037370/doc4.xml","form_type":"4"}},{"id":2007613,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Share Option (right to buy)","published_at":"2023-02-18T01:10:22.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":771000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 25% of the shares on February 17, 2024 and vests as to an additional 6.25% of the shares quarterly thereafter until February 17, 2027."}],"balance_after":771000,"derivative":{"exercise_price":4.75,"expiration_date":"2033-02-17","underlying":"Ordinary Shares","underlying_shares":771000},"source":{"system":"sec-edgar","filing":"0000899243-23-005564","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924323005564/doc4.xml","form_type":"4"}},{"id":2007612,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-02-18T01:10:22.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":29400,"price":4.04,"value":118776.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 16, 2023, the reporting person sold 29,400 ordinary shares solely to cover taxes associated with the vesting of restricted share units (\"RSUs\") on February 15, 2023. These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $4.03 to $4.17 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":407425,"source":{"system":"sec-edgar","filing":"0000899243-23-005564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924323005564/doc4.xml","form_type":"4"}},{"id":2201343,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Share Option (right to buy)","published_at":"2022-07-28T01:10:10.000Z","date":"2022-07-25","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 50% of the shares on July 25, 2023 and 50% on July 25, 2024."}],"balance_after":180000,"derivative":{"exercise_price":2.83,"expiration_date":"2032-07-25","underlying":"Ordinary Shares","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0000899243-22-026926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924322026926/doc4.xml","form_type":"4"}},{"id":2229951,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-06-16T21:00:59.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and become exercisable on the earlier of (i) June 15, 2023 or (ii) the day immediately prior to the date of the next annual meeting of stockholders following the date of grant, in each case subject to the recipient's continued service on the Board at such time."}],"balance_after":20000,"derivative":{"exercise_price":3.23,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-037486","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000120919122037486/doc4.xml","form_type":"4"}},{"id":2279314,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-05-06T23:15:10.000Z","date":"2022-05-05","kind":"sale","acquired":false,"shares":33501,"price":1.72,"value":57621.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On May 5, 2022, the reporting person sold 33,501 ordinary shares solely to cover taxes associated with the vesting of the PSUs on May 4, 2022. These sales were made pursuant to a provision in the reporting person's PSU agreement that requires automatic sales of shares to cover tax withholding obligations. The sales are intended to comply with Rule 10b5-1(c)(1)(i)(B) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $1.72 to $1.74 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":436825,"source":{"system":"sec-edgar","filing":"0000899243-22-017135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924322017135/doc4.xml","form_type":"4"}},{"id":2279313,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-05-06T23:15:10.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":92500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 7, 2019, the reporting person received performance-based restricted share units (\"PSUs\"), convertible on a one-for-one basis into ordinary shares of the issuer upon vesting. On May 4, 2022, 50% of the PSUs vested upon the issuer's achievement of the PN Chemistry Milestone (as defined in the PSU agreement) following the issuer's recent WVE-004 data release, as certified by the issuer's compensation committee."}],"balance_after":470326,"source":{"system":"sec-edgar","filing":"0000899243-22-017135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924322017135/doc4.xml","form_type":"4"}},{"id":2385362,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-02-18T23:05:20.000Z","date":"2022-02-16","kind":"sale","acquired":false,"shares":33150,"price":2.32,"value":76908.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 16, 2022, the reporting person sold 33,150 ordinary shares solely to cover taxes associated with the vesting of restricted share units (\"RSUs\") on February 15, 2022. These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $2.31 to $2.38 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":377826,"source":{"system":"sec-edgar","filing":"0000899243-22-007062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924322007062/doc4.xml","form_type":"4"}},{"id":2449256,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Share Option (right to buy)","published_at":"2022-01-05T02:17:39.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the shares on January 1, 2023 and vests as to an additional 6.25% of the shares quarterly thereafter until January 1, 2026."}],"balance_after":600000,"derivative":{"exercise_price":3.14,"expiration_date":"2032-01-01","underlying":"Ordinary Shares","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0000899243-22-000666","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924322000666/doc4.xml","form_type":"4"}},{"id":2663806,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-06-17T21:15:30.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 15, 2022 or (ii) the day immediately prior to the date of the Issuer's next\nannual meeting of stockholders following the date of grant, in each case subject to the Reporting Person's continued service on the Board."}],"balance_after":10500,"derivative":{"exercise_price":13.57,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-21-041533","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000120919121041533/doc4.xml","form_type":"4"}},{"id":2850232,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Share Option (right to buy)","published_at":"2021-02-19T00:18:32.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests as to 50% of the shares on February 15, 2022 and 50% on February 15, 2023."}],"balance_after":200000,"derivative":{"exercise_price":10.48,"expiration_date":"2031-02-01","underlying":"Ordinary Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-21-007207","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924321007207/doc4.xml","form_type":"4"}},{"id":2850231,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2021-02-19T00:18:32.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":11205,"price":10.57,"value":118436.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 16, 2021, the reporting person sold 11,205 ordinary shares solely to cover taxes associated with the vesting of RSUs on February 15, 2021. These sales were made pursuant to a 10b5-1 Trading Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $10.47 to $10.58 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":410976,"source":{"system":"sec-edgar","filing":"0000899243-21-007207","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924321007207/doc4.xml","form_type":"4"}},{"id":2850230,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2021-02-19T00:18:32.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted share units (RSUs). The RSUs vest in two equal installments on February 15, 2022 and February 15, 2023."}],"balance_after":422181,"source":{"system":"sec-edgar","filing":"0000899243-21-007207","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924321007207/doc4.xml","form_type":"4"}},{"id":2997470,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-10-30T22:30:25.000Z","date":"2020-10-29","kind":"grant","acquired":true,"shares":7055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on October 29, 2021."}],"balance_after":7055,"derivative":{"exercise_price":16,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":7055},"source":{"system":"sec-edgar","filing":"0000899243-20-029980","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924320029980/doc4.xml","form_type":"4"}},{"id":3028494,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Share Option (right to buy)","published_at":"2020-09-18T01:10:44.000Z","date":"2020-09-15","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These share options are fully vested."}],"balance_after":97778,"derivative":{"exercise_price":2.48,"expiration_date":"2025-03-10","underlying":"Ordinary Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-20-025614","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924320025614/doc4.xml","form_type":"4"}},{"id":3028493,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2020-09-18T01:10:44.000Z","date":"2020-09-15","kind":"sale","acquired":false,"shares":100000,"price":15,"value":1500000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":272181,"source":{"system":"sec-edgar","filing":"0000899243-20-025614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924320025614/doc4.xml","form_type":"4"}},{"id":3028492,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2020-09-18T01:10:44.000Z","date":"2020-09-15","kind":"exercise","acquired":true,"shares":100000,"price":2.48,"value":248000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":372181,"source":{"system":"sec-edgar","filing":"0000899243-20-025614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924320025614/doc4.xml","form_type":"4"}},{"id":3045543,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Share Option (right to buy)","published_at":"2020-08-27T22:44:46.000Z","date":"2020-08-25","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These share options are fully vested."}],"balance_after":197778,"derivative":{"exercise_price":2.48,"expiration_date":"2025-03-10","underlying":"Ordinary Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-20-023540","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924320023540/doc4.xml","form_type":"4"}},{"id":3045542,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2020-08-27T22:44:46.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":25000,"price":12,"value":300000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":272181,"source":{"system":"sec-edgar","filing":"0000899243-20-023540","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924320023540/doc4.xml","form_type":"4"}},{"id":3045541,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2020-08-27T22:44:46.000Z","date":"2020-08-25","kind":"exercise","acquired":true,"shares":25000,"price":2.48,"value":62000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":297181,"source":{"system":"sec-edgar","filing":"0000899243-20-023540","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924320023540/doc4.xml","form_type":"4"}},{"id":3091972,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Share Option (right to buy)","published_at":"2020-07-03T00:56:47.000Z","date":"2020-07-02","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These share options are fully vested."}],"balance_after":222778,"derivative":{"exercise_price":2.48,"expiration_date":"2025-03-10","underlying":"Ordinary Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-20-018398","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924320018398/doc4.xml","form_type":"4"}},{"id":3091971,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2020-07-03T00:56:47.000Z","date":"2020-07-02","kind":"sale","acquired":false,"shares":95921,"price":10.27,"value":985108.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $9.77 to $10.77 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":272181,"source":{"system":"sec-edgar","filing":"0000899243-20-018398","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924320018398/doc4.xml","form_type":"4"}},{"id":3091970,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2020-07-03T00:56:47.000Z","date":"2020-07-02","kind":"sale","acquired":false,"shares":4079,"price":10.91,"value":44501.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $10.78 to $11.12 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":368102,"source":{"system":"sec-edgar","filing":"0000899243-20-018398","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924320018398/doc4.xml","form_type":"4"}},{"id":3091969,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2020-07-03T00:56:47.000Z","date":"2020-07-02","kind":"exercise","acquired":true,"shares":100000,"price":2.48,"value":248000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":372181,"source":{"system":"sec-edgar","filing":"0000899243-20-018398","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924320018398/doc4.xml","form_type":"4"}},{"id":3091968,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2020-07-03T00:56:47.000Z","date":"2020-07-02","kind":"sale","acquired":false,"shares":43068,"price":10.26,"value":441877.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of the sale of shares that were issued upon the vesting of restricted share units. The sale was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $9.77 to $10.77 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":272181,"source":{"system":"sec-edgar","filing":"0000899243-20-018398","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924320018398/doc4.xml","form_type":"4"}},{"id":3091967,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2020-07-03T00:56:47.000Z","date":"2020-07-02","kind":"sale","acquired":false,"shares":4509,"price":10.82,"value":48787.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of the sale of shares that were issued upon the vesting of restricted share units. The sale was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $10.78 to $11.12 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":315249,"source":{"system":"sec-edgar","filing":"0000899243-20-018398","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924320018398/doc4.xml","form_type":"4"}},{"id":3224571,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Share Option (right to buy)","published_at":"2020-03-06T01:42:41.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 50% of the shares on February 1, 2021 and 50% on February 1, 2022."}],"balance_after":63000,"derivative":{"exercise_price":8.17,"expiration_date":"2030-03-03","underlying":"Ordinary Shares","underlying_shares":63000},"source":{"system":"sec-edgar","filing":"0000899243-20-007282","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924320007282/doc4.xml","form_type":"4"}},{"id":3259575,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2020-02-20T23:23:54.000Z","date":"2020-02-18","kind":"sale","acquired":false,"shares":11451,"price":7.85,"value":89890.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 18, 2020, the reporting person sold 11,451 ordinary shares solely to cover taxes associated with the vesting of restricted share units on February 15, 2020. These sales were made pursuant to a 10b5-1 Trading Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $7.84 to $8.148 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":319758,"source":{"system":"sec-edgar","filing":"0000899243-20-005349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924320005349/doc4.xml","form_type":"4"}},{"id":3586979,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Share Option (right to buy)","published_at":"2019-03-19T22:44:27.000Z","date":"2019-03-15","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These share options are fully vested."}],"balance_after":322778,"derivative":{"exercise_price":2.48,"expiration_date":"2025-03-10","underlying":"Ordinary Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-19-008404","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924319008404/doc4.xml","form_type":"4"}},{"id":3586978,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2019-03-19T22:44:27.000Z","date":"2019-03-15","kind":"sale","acquired":false,"shares":1763,"price":46,"value":81098.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $45.92 to $46.00 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":331209,"source":{"system":"sec-edgar","filing":"0000899243-19-008404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924319008404/doc4.xml","form_type":"4"}},{"id":3586977,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2019-03-19T22:44:27.000Z","date":"2019-03-15","kind":"sale","acquired":false,"shares":8237,"price":45.22,"value":372477.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $44.90 to $45.88 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":332972,"source":{"system":"sec-edgar","filing":"0000899243-19-008404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924319008404/doc4.xml","form_type":"4"}},{"id":3586976,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2019-03-19T22:44:27.000Z","date":"2019-03-15","kind":"sale","acquired":false,"shares":5065,"price":45.89,"value":232432.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $45.78 to $46.03 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":341209,"source":{"system":"sec-edgar","filing":"0000899243-19-008404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924319008404/doc4.xml","form_type":"4"}},{"id":3586975,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2019-03-19T22:44:27.000Z","date":"2019-03-15","kind":"sale","acquired":false,"shares":34935,"price":45.45,"value":1587795.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $44.78 to $45.77 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":346274,"source":{"system":"sec-edgar","filing":"0000899243-19-008404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924319008404/doc4.xml","form_type":"4"}},{"id":3586974,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2019-03-19T22:44:27.000Z","date":"2019-03-15","kind":"exercise","acquired":true,"shares":50000,"price":2.48,"value":124000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018."}],"balance_after":381209,"source":{"system":"sec-edgar","filing":"0000899243-19-008404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924319008404/doc4.xml","form_type":"4"}},{"id":3601903,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2019-03-11T23:17:03.000Z","date":"2019-03-07","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted share units (RSUs).  The RSUs vest in four equal annual installments of 25% on February 15, 2020 through February 15, 2023."}],"balance_after":331209,"source":{"system":"sec-edgar","filing":"0000899243-19-007112","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924319007112/doc4.xml","form_type":"4"}},{"id":3641925,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2019-02-22T00:51:27.000Z","date":"2019-02-19","kind":"sale","acquired":false,"shares":119,"price":37.466,"value":4458.454,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 19, 2019, the reporting person sold 7,733 ordinary shares solely to cover taxes associated with the vesting of restricted share units on February 15, 2019. These sales were made pursuant to a 10b5-1 Trading Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $37.4638 to $37.4672 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":271209,"source":{"system":"sec-edgar","filing":"0000899243-19-004464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924319004464/doc4.xml","form_type":"4"}},{"id":3641924,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2019-02-22T00:51:27.000Z","date":"2019-02-19","kind":"sale","acquired":false,"shares":7614,"price":36.38,"value":276997.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 19, 2019, the reporting person sold 7,733 ordinary shares solely to cover taxes associated with the vesting of restricted share units on February 15, 2019. These sales were made pursuant to a 10b5-1 Trading Plan."}],"balance_after":271328,"source":{"system":"sec-edgar","filing":"0000899243-19-004464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924319004464/doc4.xml","form_type":"4"}},{"id":3914182,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Share Option (right to buy)","published_at":"2018-05-31T01:18:13.000Z","date":"2018-05-30","kind":"exercise","acquired":false,"shares":20250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The share option represented a right to purchase a total of 422,778 ordinary shares that vest in thirty-six monthly installments beginning on December 12, 2014."}],"balance_after":372778,"derivative":{"exercise_price":2.48,"expiration_date":"2025-03-10","underlying":"Ordinary Shares","underlying_shares":20250},"source":{"system":"sec-edgar","filing":"0000899243-18-014497","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924318014497/doc4.xml","form_type":"4"}},{"id":3914181,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Share Option (right to buy)","published_at":"2018-05-31T01:18:13.000Z","date":"2018-05-29","kind":"exercise","acquired":false,"shares":3145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The share option represented a right to purchase a total of 422,778 ordinary shares that vest in thirty-six monthly installments beginning on December 12, 2014."}],"balance_after":393028,"derivative":{"exercise_price":2.48,"expiration_date":"2025-03-10","underlying":"Ordinary Shares","underlying_shares":3145},"source":{"system":"sec-edgar","filing":"0000899243-18-014497","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924318014497/doc4.xml","form_type":"4"}},{"id":3914180,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Share Option (right to buy)","published_at":"2018-05-31T01:18:13.000Z","date":"2018-05-25","kind":"exercise","acquired":false,"shares":8316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The share option represented a right to purchase a total of 422,778 ordinary shares that vest in thirty-six monthly installments beginning on December 12, 2014."}],"balance_after":396173,"derivative":{"exercise_price":2.48,"expiration_date":"2025-03-10","underlying":"Ordinary Shares","underlying_shares":8316},"source":{"system":"sec-edgar","filing":"0000899243-18-014497","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924318014497/doc4.xml","form_type":"4"}},{"id":3914179,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-05-31T01:18:13.000Z","date":"2018-05-30","kind":"sale","acquired":false,"shares":20250,"price":45,"value":911250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."}],"balance_after":278942,"source":{"system":"sec-edgar","filing":"0000899243-18-014497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924318014497/doc4.xml","form_type":"4"}},{"id":3914178,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-05-31T01:18:13.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":20250,"price":2.48,"value":50220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."}],"balance_after":299192,"source":{"system":"sec-edgar","filing":"0000899243-18-014497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924318014497/doc4.xml","form_type":"4"}},{"id":3914177,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-05-31T01:18:13.000Z","date":"2018-05-29","kind":"sale","acquired":false,"shares":3145,"price":45,"value":141525.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."}],"balance_after":278942,"source":{"system":"sec-edgar","filing":"0000899243-18-014497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924318014497/doc4.xml","form_type":"4"}},{"id":3914176,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-05-31T01:18:13.000Z","date":"2018-05-29","kind":"exercise","acquired":true,"shares":3145,"price":2.48,"value":7799.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."}],"balance_after":282087,"source":{"system":"sec-edgar","filing":"0000899243-18-014497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924318014497/doc4.xml","form_type":"4"}},{"id":3914175,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-05-31T01:18:13.000Z","date":"2018-05-25","kind":"sale","acquired":false,"shares":8316,"price":45,"value":374220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."}],"balance_after":278942,"source":{"system":"sec-edgar","filing":"0000899243-18-014497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924318014497/doc4.xml","form_type":"4"}},{"id":3914174,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-05-31T01:18:13.000Z","date":"2018-05-25","kind":"exercise","acquired":true,"shares":8316,"price":2.48,"value":20623.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."}],"balance_after":287258,"source":{"system":"sec-edgar","filing":"0000899243-18-014497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924318014497/doc4.xml","form_type":"4"}},{"id":3945644,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Share Option (right to buy)","published_at":"2018-05-05T00:04:29.000Z","date":"2018-05-02","kind":"exercise","acquired":false,"shares":18289,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The share option represented a right to purchase a total of 422,778 ordinary shares that vest in thirty-six monthly installments beginning on December 12, 2014."}],"balance_after":404489,"derivative":{"exercise_price":2.48,"expiration_date":"2025-03-10","underlying":"Ordinary Shares","underlying_shares":18289},"source":{"system":"sec-edgar","filing":"0000899243-18-011575","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924318011575/doc4.xml","form_type":"4"}},{"id":3945643,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-05-05T00:04:29.000Z","date":"2018-05-02","kind":"sale","acquired":false,"shares":18289,"price":45,"value":823005.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."}],"balance_after":278942,"source":{"system":"sec-edgar","filing":"0000899243-18-011575","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924318011575/doc4.xml","form_type":"4"}},{"id":3945642,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-05-05T00:04:29.000Z","date":"2018-05-02","kind":"exercise","acquired":true,"shares":18289,"price":2.48,"value":45356.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018."}],"balance_after":297231,"source":{"system":"sec-edgar","filing":"0000899243-18-011575","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924318011575/doc4.xml","form_type":"4"}},{"id":4044374,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-02-22T00:18:37.000Z","date":"2018-02-16","kind":"sale","acquired":false,"shares":2200,"price":51.62,"value":113564.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 16, 2018, the reporting person sold 2,714 ordinary shares solely to cover taxes associated with the vesting of restricted share units on February 15, 2018. These sales were made pursuant to a 10b5-1 Trading Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $51.50 to $52.10 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":278942,"source":{"system":"sec-edgar","filing":"0000899243-18-004953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924318004953/doc4.xml","form_type":"4"}},{"id":4044373,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-02-22T00:18:37.000Z","date":"2018-02-16","kind":"sale","acquired":false,"shares":514,"price":51.01,"value":26219.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 16, 2018, the reporting person sold 2,714 ordinary shares solely to cover taxes associated with the vesting of restricted share units on February 15, 2018. These sales were made pursuant to a 10b5-1 Trading Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $50.40 to $51.15 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":281142,"source":{"system":"sec-edgar","filing":"0000899243-18-004953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924318004953/doc4.xml","form_type":"4"}},{"id":4089785,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Share Option (right to buy)","published_at":"2018-01-26T01:05:19.000Z","date":"2018-01-23","kind":"grant","acquired":true,"shares":109000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% of the shares on February 15, 2019 and vests as to an additional 6.25 of the shares quarterly  thereafter until February 15, 2022."}],"balance_after":109000,"derivative":{"exercise_price":40.05,"expiration_date":"2028-01-23","underlying":"Ordinary Shares","underlying_shares":109000},"source":{"system":"sec-edgar","filing":"0000899243-18-002038","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924318002038/doc4.xml","form_type":"4"}},{"id":4089784,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares","published_at":"2018-01-26T01:05:19.000Z","date":"2018-01-23","kind":"grant","acquired":true,"shares":54500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted share units (RSUs).  The RSUs vest in four equal annual installments of 25% on February 15, 2019, through February 15, 2022."}],"balance_after":281656,"source":{"system":"sec-edgar","filing":"0000899243-18-002038","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924318002038/doc4.xml","form_type":"4"}},{"id":4479288,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Share Option (right to buy)","published_at":"2017-01-27T23:14:19.000Z","date":"2017-01-25","kind":"grant","acquired":true,"shares":72500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% of the shares on February 15, 2018 and vests as to an additional 2.0833% of the shares monthly thereafter until February 15, 2021."}],"balance_after":72500,"derivative":{"exercise_price":29.05,"expiration_date":"2027-01-25","underlying":"Ordinary Shares","underlying_shares":72500},"source":{"system":"sec-edgar","filing":"0000899243-17-002145","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924317002145/doc4.xml","form_type":"4"}},{"id":4479287,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":45244,"kind":"person","name":"BOLNO PAUL","position":1,"cik":"0001657710","reported_name":"BOLNO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares","published_at":"2017-01-27T23:14:19.000Z","date":"2017-01-25","kind":"grant","acquired":true,"shares":36300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted share units (RSUs).  The RSUs vest in four equal annual installments of 25% on February 15, 2018, through February 15, 2021."}],"balance_after":227156,"source":{"system":"sec-edgar","filing":"0000899243-17-002145","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657710/000089924317002145/doc4.xml","form_type":"4"}}]}